Picture of NVN Liquidation logo

NOVNQ — NVN Liquidation News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapNeutral

Brief: Results From Novan’S Exploratory Studies Further Demonstrate Antimicrobial Effect Of Nitricil™ Platform Technology With Nvn4100 In Companion Animal Health

June 7 (Reuters) - Novan Inc  NOVN.O :
    * RESULTS FROM NOVAN’S EXPLORATORY STUDIES FURTHER
DEMONSTRATE
ANTIMICROBIAL EFFECT OF NITRICIL™ PLATFORM TECHNOLOGY WITH
NVN4100 IN COMPANION ANIMAL HEALTH
    * NOVAN INC - POSITIVE IN VITRO RESULTS DEMONSTRATE
ANTIMICROBIAL
EFFECT OF NVN4100 AGAINST A WIDE VARIETY OF BACTERIA
    * NOVAN INC - NOVEL IN VIVO CANINE PYODERMA MODEL
ESTABLISHED
WHICH SERVES AS A TOOL FOR CONTINUED ASSESSMENT AND OPTIMIZATION
OF NEXT STEPS

Source text for Eikon:  ID:nGNX6GdxnF 
Further company coverage:  NOVN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on NVN Liquidation

See all news